Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...

A class of ultrasmall fluorescent core-shell silica nanoparticles is showing an unexpected ability to rally the immune system ...

I failed an exam for the first time as a third-year in college. And the worst part? It was a class filled with mostly ...

Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 ...

Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today ...

The economic and social effects of massive wealth transfers between generations are not being taken seriously.

Interstellar comet 3I/ATLAS is giving astronomers a rare, close look at material that formed far beyond our planetary ...